CN102746209A - A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione - Google Patents

A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione Download PDF

Info

Publication number
CN102746209A
CN102746209A CN2012102039670A CN201210203967A CN102746209A CN 102746209 A CN102746209 A CN 102746209A CN 2012102039670 A CN2012102039670 A CN 2012102039670A CN 201210203967 A CN201210203967 A CN 201210203967A CN 102746209 A CN102746209 A CN 102746209A
Authority
CN
China
Prior art keywords
phenyl
chlorophenoxy
methyl
diketone
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012102039670A
Other languages
Chinese (zh)
Inventor
李春雷
丁炬平
张仁延
余强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cgenetech Suzhou China Co Ltd
Original Assignee
Cgenetech Suzhou China Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cgenetech Suzhou China Co Ltd filed Critical Cgenetech Suzhou China Co Ltd
Priority to CN2012102039670A priority Critical patent/CN102746209A/en
Publication of CN102746209A publication Critical patent/CN102746209A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione which is an important intermediate for the synthesis of asenapine. Under current technology conditions, according to the method, 3-(2-(4-chlorophenoxy)phenyl)-1-methyl-2,4-dione is obtained through two simple reaction using 2-(2-(4-chlorophenyl)phenyl) acetate as a starting material. The method explores and optimizes the synthetic route of 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione. The method is advantaged by simple and safe operation, low material cost, and suitability for mass production in factories.

Description

A kind of 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the compound method of 4-diketone
Technical field
The present invention relates to a kind of 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the synthesis technology of 4-diketone improves, and belongs to medicine, chemical technology field.
Background technology
3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the 4-diketone is a kind of white solid, is the flat important intermediate raw material of synthetic Arsenal.
Summary of the invention
The present invention is being under the prerequisite of raw material with 2-(2-(4-chloro-phenyl-) phenyl) acetate, attempted three condition circuits after, finally confirmed the technology circuit of this patent.Article one, attempting circuit is; 2-(2-(4-chloro-phenyl-) phenyl) acetate obtains 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min. under the condition that sulfur oxychloride refluxes, and then through N; Dinethylformamide; The processing of triethylamine and hydrochloride methyl sarcosnate obtain methyl-2-(2-(2-(4-chlorophenoxy) phenyl)-N-methylacetamido) acetic acid, the processing through toluene and potassium tert.-butoxide just can obtain 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2,4-diketone then; The consumption of this method sulfur oxychloride is too big; Environmental pollution is more serious, and the removal of the sulfur oxychloride that cost is high and excessive is also very complicated, and effect is bad on the whole.Second is attempted route and is to use oxalyl chloride to replace sulfur oxychloride; Make solvent with methylene dichloride; 2-(2-(4-chloro-phenyl-) phenyl) acetate is made 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min., and the back is operated identical, and the reaction of this method generation 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min. is relatively poor; Its result has caused 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, and the productive rate of 4-diketone declines to a great extent.The third method is; Make 2-(2-(4-chloro-phenyl-) phenyl) acetate change into 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min. with oxalyl chloride and THF processing; The result shows that reaction is fine, has not only reduced production cost, and has greatly reduced the pollution to environment.
3-according to the invention (2-(4-chlorophenoxy) phenyl)-1-methyl-2, the compound method of 4-diketone is to be raw material with 2-(2-(4-chloro-phenyl-) phenyl) acetate; Handle at normal temperatures with oxalyl chloride and THF, obtain 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min., 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min. of gained is added drop-wise to the N that contains hydrochloride methyl sarcosnate and triethylamine under the condition below 10 degree; In the dinethylformamide solution; Stirred overnight at room temperature reacts completely, and reaction solution is poured in the water; Ethyl acetate extraction; Washing ETHYLE ACETATE, anhydrous sodium sulfate drying selects dried methyl-2-(2-(2-(4-chlorophenoxy) phenyl)-N-methylacetamido) bullion of acetic acid that obtains.(2-(2-(4-chlorophenoxy) phenyl)-N-methylacetamido) bullion of acetic acid is dissolved in and slowly is added drop-wise in the toluene in the toluene that contains potassium tert.-butoxide, and mechanical stirring 30 minutes reacts completely with methyl-2-.To react and also pour in the water, separatory, water with concentrated hydrochloric acid acid adjustment degree to about the neutrality; Have the tawny solid to separate out, filter, the tawny solid is washed with the mixing solutions of ETHYLE ACETATE and toluene; Solid becomes white; Filter, obtaining white solid is 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the pure article of 4-diketone.
Above-mentioned 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the compound method of 4-diketone is characterized in that: the consumption of said oxalyl chloride is the twice of the amount of substance of 2-(2-(4-chloro-phenyl-) phenyl) acetate.
Above-mentioned 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2; 4-diketone compound method; It is characterized in that: the said THF that uses is the dry THF of crossing of sodium silk, and consumption is the THF of five milliliters of each gram 2-(2-(4-chloro-phenyl-) phenyl) acetate.
Above-mentioned 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the compound method of 4-diketone is characterized in that the gained midbody does not need purifying, can directly carry out next step reaction.
Above-mentioned is the synthetic 3-(2-(4-chlorophenoxy) phenyl) of raw material-1-methyl-2 with 2-(2-(4-chloro-phenyl-) phenyl) acetate, and the chemical reaction and the reaction formula of 4-diketone are following:
(1) reaction equation of Synthetic 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min. is:
Figure 960807DEST_PATH_IMAGE001
(2) reaction is accomplished, and revolves the reaction equation of doing the back direct reaction to be:
Figure 802862DEST_PATH_IMAGE002
(3) reaction is accomplished, and the gained bullion continues the reactionization reaction equation and is:
(4) react completely after, pour in the water, separatory, water is transferred to neutrality with concentrated hydrochloric acid, separates out solid, solid is washed 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the pure article of 4-diketone of obtaining with the mixing solutions of ETHYLE ACETATE and sherwood oil.
Embodiment
Embodiment:
Said 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2; The compound method of 4-diketone makes: in 10 liters there-necked flask, add 948 gram 2-(2-(4-chloro-phenyl-) phenyl) acetate; 4740 milliliters THF, room temperature condition slowly drip the oxalyl chloride of 910 grams (2 equivalent) down, after the dropping fully; The N of slow Dropwise 5 milliliter; Dinethylformamide (reacting very violent), room temperature continue to stir one hour, revolved the bullion of dried 1320 gram 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min.s.1500 milliliters of N, dinethylformamide dissolve away 1320 gram 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min.s, and under the condition below 10 degree, slowly are added drop-wise to and contain 526 (1.2 equivalents) and restrain hydrochloride methyl sarcosnate; 3500 milliliters of N, dinethylformamide is in the there-necked flask of 1161 grams (3.2 equivalent); In the dropping process, keep temperature to be lower than 10 degree, after the dropping fully; Stirred overnight at room temperature reacts completely.Reaction solution is poured in 8 premium on currency, used 5000 milliliters respectively, 3000 milliliters 2000 milliliters ethyl acetate extraction once merges organic phase.2000 milliliters of washings 2 times, anhydrous sodium sulfate drying revolves dried methyl-2-(bullion 931 grams of 2-(2-(4-chlorophenoxy) phenyl)-N-methylacetamido) acetic acid.Purifying does not directly carry out next step reaction.In 10 liters there-necked flask, drop into the potassium tert.-butoxide of 600 grams (2 equivalent), 5000 milliliters toluene, mechanical stirring; ((2-(4-chlorophenoxy) phenyl)-N-methylacetamido) bullion of acetic acid (being untreated) is dissolved in 1500 milliliters of toluene 2-, is added drop-wise in the reaction flask, drips fully in 30 minutes with 931 gram methyl-2-; After dripping fully, stirring at room 30 minutes, TLC point plate; React completely (thermopositive reaction), reaction solution is poured in 8000 ml waters, mechanical stirring 30 minutes; Separatory, water is jumped about acidity to 2 with concentrated hydrochloric acid, has a large amount of off-white color solids to separate out; Filter, solid filters with 1000 milliliters of washings 2 times; (ETHYLE ACETATE: wash, and filters 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the pure article of 4-diketone of obtaining by the mixing solutions of sherwood oil=1:2) with 1500 milliliters of ETHYLE ACETATE and sherwood oil for solid.

Claims (5)

  1. (1.3-2-(4-chlorophenoxy) phenyl)-1-methyl-2, the compound method of 4-diketone is that employing 2-(2-(4-chloro-phenyl-) phenyl) acetate is raw material; Handle at normal temperatures with oxalyl chloride and THF, obtain 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min., 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min. of gained is added drop-wise to the N that contains hydrochloride methyl sarcosnate and triethylamine under the condition below 10 degree; In the dinethylformamide solution, stirred overnight at room temperature reacts completely; Reaction solution is poured in the water into ethyl acetate extraction, washing ETHYLE ACETATE; Anhydrous sodium sulfate drying, revolve dried obtain methyl-2-(2-(2-(4-chlorophenoxy) phenyl)-N-methylacetamido) bullion of acetic acid, ((2-(4-chlorophenoxy) phenyl)-N-methylacetamido) bullion of acetic acid is dissolved in and slowly is added drop-wise in the toluene that contains potassium tert.-butoxide in the toluene 2-with methyl-2-; Mechanical stirring 30 minutes reacts completely, and will react and also pour in the water; Separatory, water to about the neutrality, has the tawny solid to separate out with concentrated hydrochloric acid acid adjustment degree; Filter, the tawny solid is washed with the mixing solutions of ETHYLE ACETATE and toluene, and solid becomes white; Filter, obtain pure 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2, the 4-diketone.
  2. 2. as claimed in claim 3,4-dihydro-2H-pyrans is the compound method of [3,2-b] pyridine also, it is characterized in that: described initial feed is meant that with 2-(2-(4-chloro-phenyl-) phenyl) acetate be raw material.
  3. 3. 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2 as claimed in claim, the compound method of 4-diketone is characterized in that: use oxalyl chloride to replace sulfur oxychloride.
  4. 4. 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2 as claimed in claim, the compound method of 4-diketone is characterized in that: to be that the sodium silk is dry cross employed THF.
  5. 5. 3-(2-(4-chlorophenoxy) phenyl)-1-methyl-2 as claimed in claim, the compound method of 4-diketone is characterized in that: the temperature when dripping 2-(2-(4-chlorophenoxy) phenyl) Acetyl Chloride 98Min. is 10 to spend.
CN2012102039670A 2012-06-20 2012-06-20 A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione Pending CN102746209A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012102039670A CN102746209A (en) 2012-06-20 2012-06-20 A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012102039670A CN102746209A (en) 2012-06-20 2012-06-20 A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione

Publications (1)

Publication Number Publication Date
CN102746209A true CN102746209A (en) 2012-10-24

Family

ID=47026766

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012102039670A Pending CN102746209A (en) 2012-06-20 2012-06-20 A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione

Country Status (1)

Country Link
CN (1) CN102746209A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102976998A (en) * 2012-11-26 2013-03-20 盛世泰科生物医药技术(苏州)有限公司 Method for synthesizing 3-(5-chloro-2-phenoxy-phenyl)-1-methyl-pyrrolidine-2, 4-diketone
US11033512B2 (en) 2017-06-26 2021-06-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
US11337932B2 (en) 2016-12-20 2022-05-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
US11648213B2 (en) 2018-06-20 2023-05-16 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101175741A (en) * 2005-04-07 2008-05-07 欧加农股份有限公司 Intermediate compounds for the prepation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-C]pyrrole
CN101563312A (en) * 2006-12-22 2009-10-21 住友化学株式会社 Process for producing intermediate of asenapine synthesis
WO2011159903A2 (en) * 2010-06-18 2011-12-22 Dr. Reddy's Laboratories Ltd. Asenapine maleate
WO2012038975A2 (en) * 2010-09-22 2012-03-29 Msn Laboratories Limited Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101175741A (en) * 2005-04-07 2008-05-07 欧加农股份有限公司 Intermediate compounds for the prepation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-C]pyrrole
CN101563312A (en) * 2006-12-22 2009-10-21 住友化学株式会社 Process for producing intermediate of asenapine synthesis
WO2011159903A2 (en) * 2010-06-18 2011-12-22 Dr. Reddy's Laboratories Ltd. Asenapine maleate
WO2012038975A2 (en) * 2010-09-22 2012-03-29 Msn Laboratories Limited Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102976998A (en) * 2012-11-26 2013-03-20 盛世泰科生物医药技术(苏州)有限公司 Method for synthesizing 3-(5-chloro-2-phenoxy-phenyl)-1-methyl-pyrrolidine-2, 4-diketone
US11337932B2 (en) 2016-12-20 2022-05-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
US11033512B2 (en) 2017-06-26 2021-06-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
US11648213B2 (en) 2018-06-20 2023-05-16 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Similar Documents

Publication Publication Date Title
CN103524440B (en) The preparation method of gout therapertics Lesinurad and Lesinurad intermediate
CN103058993B (en) Chlorantraniliprole preparation method
CN102746209A (en) A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione
CN101434610B (en) Penam iodide, preparation and use thereof
CN102827156A (en) Novel industrial synthetic method of dasatinib
CN106699570A (en) Synthesis method for (2-chloro-5-iodophenyl)(4-fluorophenyl)ketone
CN103204823B (en) Method for purifying 1, 2-benzisothiazole-3-ketone
CN107628990B (en) Synthesis method of 5-bromopyridine-3-formaldehyde
CN102796079A (en) Method for preparing flumatinib mesylate
CN105061405A (en) Preparation method of fimasartan potassium salt hydrate
CN103172583A (en) Parecoxib preparation method
CN102976998A (en) Method for synthesizing 3-(5-chloro-2-phenoxy-phenyl)-1-methyl-pyrrolidine-2, 4-diketone
CN103012300A (en) Novel method for preparing valsartan
CN105693737B (en) Bipyridine ligand with axial chirality and synthetic method thereof
CN101973960B (en) Improved method for preparing benzo[d][1,2,3] thiadiazole-7-formic acid trifluoroacetate
CN101418005B (en) Novel method for synthesizing prulifloxacin
CN106008436A (en) Preparation method of alpha crystal form of Iguratimod
CN102936223A (en) Synthesis method and purification method of 5-iodo-2-methylbenzimidazole
CN105017284B (en) The Preparation Method And Their Intermediate of ceftizoxime alapivoxil and the preparation method of intermediate
CN103992357B (en) Macromolecule crosslink agent containing multi-metal oxygen cluster and its preparation method and application
CN101696185B (en) Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid
CN101391969B (en) Method for preparing N-methyl-2-(2,4-dichlorophenoxy) acetamide
CN102382100A (en) Preparation method of imatinib
CN102584811A (en) Method for preparing aztreonam
CN102617376A (en) Synthesis method of calcium ion selective chelating agents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121024